Korean mummies may provide clues to combat hepatitis BJuly 26, 2007Mummies that have recently been unearthed in South Korea may provide clues on how to combat hepatitis B, according to Prof. Mark Spigelman of the Kuvin Center for the Study of Infectious and Tropical Diseases at the Hebrew University of Jerusalem. This is the first time that samples of hepatitis B have ever been found on a mummified body. When the virus was discovered in the liver of a 500 year old child, researchers at Dankook University and Seoul National University invited Hebrew University Prof Spigelman to South Korea to verify the findings. Spigelman and the Liver Unit at Hadassah University Hospital-Ein Kerem in Jerusalem are now part of an international team to conduct research on the mummies, bringing together experts from Dankook University, Seoul National University and University College London.
Spigelman known for his pioneering studies of ancient diseases (palaeoepidemiology) found on mummified bodies from Hungary to Sudan, in his quest to provide answers to the development of diseases affecting us today, such as tuberculosis, leishmania and influenza. The South Korean mummies are particularly well preserved, and could provide crucial information in the evolution of the hepatitis B virus. An international killer Hepatitis B causes liver problems and can lead to liver cancer or liver failure, killing approximately one million people each year. In South Korea, the need to manage the virus is particularly significant, as twelve percent of the population are hepatitis carriers (compared with a world average of five percent). In China, the virus is one of the leading causes of cancer. Korean mummies? Until recently, no one even knew that mummies existed in Korea. Korea's ancient tradition of ancestor worship and the belief that at death, the soul rises up and the body has to go back to its natural components, without interference by external elements, meant that mummification was in fact anathema in Korean culture. However, with the take-over of the neo-Confucianist Joseon Dynasty in 1392, changes were made to the former Buddhist burial practices. The burial process involved laying the body on ice for three to thirty days during mourning, placing the body inside an inner and an outer pine coffin, surrounded by the deceased's clothes, and the covering he coffin in a lime soil mixture. "In some cases, this inadvertently resulted in extremely good natural mummification," says Spigelman. The building boom in South Korea has meant that many cemeteries have had to be relocated. It is this process which led to the discovery of the mummified bodies. Know your enemy The researchers intend to study the genome of the 500 year old virus to see if there have been any significant changes over this time. Spigelman asks: "Five hundred years ago, was it hepatitis B" Could it be that later on, it split from 'X' and became A and B" Was it already evolved" That's what we don't know." "This is a 'know your enemy' expedition to see if we can get information that can help today's - and tomorrow's - sufferers," says Spigelman. He believes that knowing what a virus did 500 years ago helps us understand what it will do as it continues to evolve, and will ultimately alter the practice of public health officials in combating it. The Hebrew University of Jerusalem | |||||||||||||||||||||
|
Related Hepatitis Current Events and Hepatitis News Articles Common cold virus came from birds A virus that causes cold-like symptoms in humans originated in birds and may have crossed the species barrier around 200 years ago, according to an article published in the December issue of the Journal of General Virology. Scientists hope their findings will help us understand how potentially deadly viruses emerge in humans. Study finds Canada's supervised injection facility cost-effective Canada's only supervised injection facility is extending lives and saving the health-care system millions of dollars, a new study shows. Tibotec presents interim findings for TMC435, an investigational genotype 1 hepatitis C treatment New clinical data show antiviral activity of TMC435, an investigational protease inhibitor (PI) being developed by Tibotec BVBA for the treatment of chronic hepatitis C virus (HCV) infection. Mayo Clinic's new imaging technology accurately identifies a broad spectrum of liver disease A new study shows that an imaging technology developed by Mayo Clinic researchers can identify liver fibrosis with high accuracy and help eliminate the need for liver biopsies. Liver fibrosis is a common condition that can lead to incurable cirrhosis if not treated in time. Pakistan introduces vaccine to prevent top child killer This month, Pakistan is introducing a new combination vaccine that will protect its children against the bacterium Haemophilus influenzae type b (Hib) and four other common childhood diseases. Are bone marrow mononuclear cells effective in reducing hepatic lesions? Liver fibrosis occurs in the setting of chronic injury caused by different etiologies constituting a serious worldwide public health problem. In addition to schistosomiasis, hepatopathies due to alcohol, viral hepatitis, drugs, metabolic and autoimmune diseases, and congenital abnormalities are important causes of liver fibrosis. Adult liver transplant eligibility criteria The pain is debilitating. The only option: smoking medical marijuana. That's the reality for many hepatitis C patients whose road to health includes a liver transplant. The risk factors of idiopathic pulmonary fibrosis in HCV patients Hepatitis C virus (HCV) is one of the more common causes of chronic liver disease in world with a variety of extrahepatic complications such as essential mixed cryoglobulinemia, membranoproliferative glomerulonep hritis, autoimmune thyroiditis, sialadenitis, and cardiomyopathy. $2 egg-beater could save lives in developing countries Plastic tubing taped to a handheld egg-beater could save lives in developing countries, the Royal Society of Chemistry's journal Lab on a Chip reports Body's anti-HIV drug explained Humans have a built-in weapon against HIV, but until recently no one knew how to unlock its potential. More Hepatitis Current Events and Hepatitis News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||